iBio, Inc. (NYSEMKT:IBIO – Get Free Report)’s share price was up 2.3% during mid-day trading on Wednesday . The stock traded as high as $0.88 and last traded at $0.87. Approximately 372,569 shares were traded during trading, an increase of 229% from the average daily volume of 113,212 shares. The stock had previously closed at $0.85.
iBio Trading Down 0.3%
The firm has a market capitalization of $17.03 million, a PE ratio of -0.50 and a beta of 0.89. The company’s 50-day moving average price is $0.78 and its 200-day moving average price is $1.10. The company has a debt-to-equity ratio of 0.04, a quick ratio of 0.91 and a current ratio of 0.91.
iBio Company Profile
iBio, Inc, a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company’s technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein.
Further Reading
- Five stocks we like better than iBio
- Investing in Travel Stocks Benefits
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- What is a buyback in stocks? A comprehensive guide for investors
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Receive News & Ratings for iBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iBio and related companies with MarketBeat.com's FREE daily email newsletter.
